FTX-6746

• CAT Number: I041283
• CAS Number: 2829349-96-2
• Molecular Formula: C16H7ClF2N2O
• Molecular Weight: 316.69
• Purity: ≥95%
• Synonyms: 4-chloro-3-(5,7-difluoro-4-oxo-1H-quinolin-2-yl)benzonitrile
• InChI: InChI=1S/C16H7ClF2N2O/c17-11-2-1-8(7-20)3-10(11)13-6-15(22)16-12(19)4-9(18)5-14(16)21-13/h1-6H,(H,21,22)
• InChIKey: PCCCYEBARWZCEY-UHFFFAOYSA-N
• SMILES: C1=CC(=C(C=C1C#N)C2=CC(=O)C3=C(N2)C=C(C=C3F)F)Cl

FTX-6746（Cat No.:I041283）is an investigational drug in early-stage development targeting cancer, specifically for solid tumors. It functions as a potent inhibitor of key proteins involved in tumor cell proliferation and survival. By modulating specific molecular pathways, FTX-6746 aims to suppress tumor growth, enhance apoptosis, and improve patient outcomes when combined with other cancer therapies. Preclinical studies have shown promising efficacy, making FTX-6746 a potential breakthrough in oncology treatment. It is being developed by FTX Pharmaceuticals with the goal of offering more effective, targeted cancer therapies with minimal side effects.